234 related articles for article (PubMed ID: 31978440)
1. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder.
Cuperfain AB; Kennedy JL; Gonçalves VF
Neurosci Biobehav Rev; 2020 Apr; 111():125-134. PubMed ID: 31978440
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.
Calkin CV
Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713
[TBL] [Abstract][Full Text] [Related]
3. Neuroprogression and illness trajectories in bipolar disorder.
Kapczinski NS; Mwangi B; Cassidy RM; Librenza-Garcia D; Bermudez MB; Kauer-Sant'anna M; Kapczinski F; Passos IC
Expert Rev Neurother; 2017 Mar; 17(3):277-285. PubMed ID: 27659841
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and pathological brain ageing.
Cholerton B; Baker LD; Craft S
Diabet Med; 2011 Dec; 28(12):1463-75. PubMed ID: 21974744
[TBL] [Abstract][Full Text] [Related]
5. Bipolar disorders, type 2 diabetes mellitus, and the brain.
Hajek T; McIntyre R; Alda M
Curr Opin Psychiatry; 2016 Jan; 29(1):1-6. PubMed ID: 26575297
[TBL] [Abstract][Full Text] [Related]
6. [Neuroprogression and cognition in Bipolar Disorders: A systematic review of cognitive performance in euthymic patients].
Lolich M; Holtzman JN; Rago CM; Vázquez GH
Vertex; 2015; 26(122):265-75. PubMed ID: 26672503
[TBL] [Abstract][Full Text] [Related]
7. From neuroprogression to neuroprotection: implications for clinical care.
Berk M; Conus P; Kapczinski F; Andreazza AC; Yücel M; Wood SJ; Pantelis C; Malhi GS; Dodd S; Bechdolf A; Amminger GP; Hickie IB; McGorry PD
Med J Aust; 2010 Aug; 193(S4):S36-40. PubMed ID: 20712560
[TBL] [Abstract][Full Text] [Related]
8. Areas of controversy in neuroprogression in bipolar disorder.
Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F
Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559
[TBL] [Abstract][Full Text] [Related]
9. Cortisol levels in fingernails, neurocognitive performance and clinical variables in euthymic bipolar I disorder.
Herane-Vives A; Cleare AJ; Chang CK; de Angel V; Papadopoulos A; Fischer S; Halari R; Cheung EYW; Young AH
World J Biol Psychiatry; 2018 Dec; 19(8):633-644. PubMed ID: 28345388
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.
Menkes MW; Armstrong K; Blackford JU; Heckers S; Woodward ND
Schizophr Res; 2019 Apr; 206():413-419. PubMed ID: 31104720
[TBL] [Abstract][Full Text] [Related]
11. Brain insulin resistance deteriorates cognition by altering the topological features of brain networks.
Su F; Shu H; Ye Q; Wang Z; Xie C; Yuan B; Zhang Z; Bai F
Neuroimage Clin; 2017; 13():280-287. PubMed ID: 28050343
[TBL] [Abstract][Full Text] [Related]
12. Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
Fiore V; De Rosa A; Falasca P; Marci M; Guastamacchia E; Licchelli B; Giagulli VA; De Pergola G; Poggi A; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2019; 19(5):571-579. PubMed ID: 30854980
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and outcome in bipolar disorder.
Calkin CV; Ruzickova M; Uher R; Hajek T; Slaney CM; Garnham JS; O'Donovan MC; Alda M
Br J Psychiatry; 2015 Jan; 206(1):52-7. PubMed ID: 25323142
[TBL] [Abstract][Full Text] [Related]
14. Mediators of allostasis and systemic toxicity in bipolar disorder.
Grande I; Magalhães PV; Kunz M; Vieta E; Kapczinski F
Physiol Behav; 2012 Apr; 106(1):46-50. PubMed ID: 22079584
[TBL] [Abstract][Full Text] [Related]
15. Cognitive decline and neuroprogression in bipolar disorder: A case for Hitchens' razor.
Szmulewicz A; Valerio M; Martino DJ
Bipolar Disord; 2020 Aug; 22(5):536. PubMed ID: 32521083
[No Abstract] [Full Text] [Related]
16. From obesity to Alzheimer's disease through insulin resistance.
Terzo S; Amato A; Mulè F
J Diabetes Complications; 2021 Nov; 35(11):108026. PubMed ID: 34454830
[TBL] [Abstract][Full Text] [Related]
17. Biological mechanisms underlying neuroprogression in bipolar disorder.
Budni J; Valvassori SS; Quevedo J
Braz J Psychiatry; 2013 Mar; 35(1):1-2. PubMed ID: 23567592
[No Abstract] [Full Text] [Related]
18. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.
Barichello T; Giridharan VV; Bhatti G; Sayana P; Doifode T; Macedo D; Quevedo J
Curr Top Behav Neurosci; 2021; 48():215-237. PubMed ID: 33040314
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: associations and a hypothesis.
Domínguez RO; Pagano MA; Marschoff ER; González SE; Repetto MG; Serra JA
Neurologia; 2014; 29(9):567-72. PubMed ID: 24140159
[TBL] [Abstract][Full Text] [Related]
20. Inside the diabetic brain: Insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies.
Dutta BJ; Singh S; Seksaria S; Das Gupta G; Singh A
Pharmacol Res; 2022 Aug; 182():106358. PubMed ID: 35863719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
